Newsletter subscription & archive

High Tea event in September: Awareness of ovarian cancer


Written byRandi Munch Krogsgaard

September is international Ovarian Cancer Awareness Month, and following our strategical focus on personalised medicine, Biopeople has joined forces with OvaCure to raise awareness about ovarian cancer

On 17 September 2019, we will host a High Tea Event at the Maersk Tower to talk about ovarian cancer under the theme “Women’s Health & Rights”. At this point, the event is fully booked and people who are interested to join may sign up for the waiting list.

Ovarian cancer deserves focus
Ovarian cancer is the seventh most common cancer, and eighth most common cause of death from cancer in women in the world. In 2012, the estimate was that 239,000 women worldwide had ovarian cancer, and that 152,000 women died from the disease (representing 3.6% of cancer cases, and 4.3% of cancer deaths).

Almost 600,000 women worldwide live within five years of an ovarian cancer diagnosis (5-year prevalence). By 2035, the estimate is that the incidence will increase by 55% to 371,000 cases a year and deaths will increase by 67% to 254,000 deaths worldwide per year. (Source: THE WORLD OVARIAN CANCER COALITION ATLAS, GLOBAL TRENDS IN INCIDENCE, MORTALITY AND SURVIVAL, © World Ovarian Cancer Coalition 2018)

Due to diffuse symptoms, ovarian cancer is difficult to diagnose, and approximately 70% of women diagnosed with ovarian cancer are in an advanced stage of the disease and difficult to treat. This means that overall survival rates for ovarian cancer are poor, which provides a consistent imperative to seek improvements in diagnosis and treatment globally.

A great afternoon with a nice cup of tea
The High Tea event in September offers a nice opportunity to meet among others Dr Henriette Svarre Nielsen, Rigshospitalet, Professor Inge Marie Svane, Herlev Hospital and Dr Mansoor Raza Mirza, Rigshospitalet as well as about 70 attendees.

About OvaCure

OvaCure is a Danish not-for-profit organization that brings together leading international experts within ovarian cancer, immunotherapy, oncology and innovative technologies to co- create innovative research projects – with the vision to cure ovarian cancer.


What are you looking for?